Archives
23andMe Responds to FDA, Halts Health Analysis of Genetic Results - For Now
Genetic test maker 23andMe issued a statement Thursday announcing its decision to stop offering its signature service while the company goes forward with the Food and Drug Administration's (FDA) review processes surrounding it.
Latest Research Articles
How Mosquitoes Hunt Humans [VIDEO]
Skin 'Talks' to the Liver [VIDEO]
Curiosity Passes Yet Another Milestone, Firing its Laser for 100,000th Time
Heavy Tourist Feeding Leads to Nutrition Imbalance in Bahamian Rock Iguanas
Fruit Flies Hide Their Eggs in Oranges to Protect from Parasitic Wasps
FDA Okays Gilead's $1,000-a-day Drug for Hepatitis C
Gut Bacteria Linked with Colorectal Cancer
Mindful Meditation Reduces Stress by Altering Gene Expression, Study Finds
FDA Approves Xiaflex for Peyronie’s disease
Deforestation May Offer Climate, Economic Benefits in Certain Areas
Primate Eating Habits Revealed in First In-depth Analysis
Global Fishing Meeting Ends in 'Failure' to Protect Tuna
MOST POPULAR
-
How Wildlife Corridors Create Lifelines for Animals Facing Habitat Loss and Fragmentation
-
Why Are Coral Reefs Bleaching Faster Than Ever—and Can They Actually Recover?
-
How Community Conservation Programs Protect Wildlife and Build Sustainable Futures for Everyone
-
Safeguarding the Wild: National Parks That Shield Earth's Rarest Animals
-
Antarctica Hidden Mountains: Stunning Map Reveals Secret Peaks Under Ice Sheet
